What was once claimed as a blockbuster drug, Glaxo announced today 4rth quarter Benlysta sales of only 43 million dollars. At this rate, it will take Glaxo 15 years to get back the cost of discovering, testing and selling the drug. Pretty pathetic number considering the drug has been on the market for over 2 years. And makes you realize why no one will front Anthera any money to take the drug to phase III. Considering you have an extremely risky phase III trial and then a market that is tiny, there is really no reason to go out on a limb. The execs of Anthera realize this... Just a matter of time before they call it quits.